EyesVision Corporation (031310) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for EyesVision Corporation (031310:KRX), powered by AI.

Current Price
₩2,175
P/E Ratio
-36.0
Market Cap
57.3B
Sector
Common Stock
What is the EyesVision Corporation stock price forecast?

EyesVision Corporation is currently trading at ₩2,175. View real-time AI analysis on Alpha Lenz.

What is EyesVision Corporation insider trading activity?

View the latest insider trading data for EyesVision Corporation on Alpha Lenz.

What is EyesVision Corporation's P/E ratio?

EyesVision Corporation's P/E ratio is -36.0.

EyesVision Corporation

KRX · 031310
₩2,175
Ask about EyesVision Corporation's future dividend policy...
Alpha Chat Insight

EyesVision Corporation trades at a P/E of -36.0 (undervalued) with modest ROE of -1.0%.

Ask for details

Company Overview

EyesVision Corporation is a prominent player in the healthcare sector, specifically focusing on the development and manufacturing of advanced ophthalmic products. The company's primary function is to innovate and deliver cutting-edge solutions for eye care, including diagnostic technologies and therapeutic treatments. EyesVision's products cater to a broad range of eye conditions, impacting both preventative care and advanced medical interventions. The corporation works closely with ophthalmologists, clinics, and healthcare facilities to ensure that their offerings meet the evolving needs of the industry and adhere to rigorous regulatory standards. A key characteristic of EyesVision is its commitment to research and development, which positions it at the forefront of new technologies and treatment methodologies that enhance visual health. In the financial market, EyesVision Corporation plays a crucial role by contributing to the healthcare and life sciences sectors, and its initiatives often influence trends in medical technology and patient care. Through its innovative approach, EyesVision supports the global endeavor to improve eye health and access to quality ophthalmic care.

CEO김상우 , 안필성(각자 대표이사)
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2024

Profile

₩57,322,218,525Market Cap
₩182,782,663,550Revenue
26.36MShares Out
0Employees

Margins

18.54%Gross
-1.23%EBITDA
0.56%Operating
0.74%Pre-Tax
-0.47%Net

Valuation

-36.00P/E
0.34P/B
0.27EV/Sales
-40.01EV/EBITDA
14.12P/FCF

Growth (CAGR)

8.02%Rev 3Yr
6.80%Rev 5Yr
-50.38%Op Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.35%ROA
-0.99%ROE
1.39%ROIC

Financial Health

₩26,174,297,300Cash & Cash Equivalents
₩20,965,011,400Net Debt
24.42%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

EyesVision Corporation trades at a P/E of -36.0 (undervalued) with modest ROE of -1.0%.

Ask for details

Frequently Asked Questions

EyesVision Corporation (ticker: 031310) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $57.3B.

The current price is ₩2,175 with a P/E ratio of -36x and P/B of 0.34x.

ROE is -0.99% and operating margin is 0.56%. Annual revenue is $182.8B.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
EyesVision Corporation (Common Stock) Stock Forecast & Analysis ₩2,175 | Alpha Lenz